With its remote endovascular procedure system currently under review at the FDA, Microbot Medical has put forward positive results from a pivotal study touting a 100% satisfaction rate among ...
The Webinar, Which is Suitable to All Stakeholders Interested in the Future of Endovascular Robotics, Will be Held on Wednesday, December 21, 2022, at 1:00pm ET Dr. Ripal Gandhi, a Renowned ...
Microbot Medical Inc. announced that it has received an important patent in China for its LIBERTY Endovascular Robotic System, enhancing its global intellectual property strategy. This patent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results